Skip to main content

Advertisement

Log in

Kaletra® Single Agent HAART after Intolerance of NRTI- and NNRTI-Containing Regimens Following Kidney Transplantation

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

Abstract

We report on a patient who received a diagnosis of HIV infection following kidney transplantation some years earlier. As a result of intolerance and failure of nucleoside and non-nucleoside reverse transcriptase inhibitor (NRTI and NNRTI)-containing regimens, he was started on Kaletra® single agent HAART. Kaletra® was well tolerated and resulted in sustained viral load suppression below the limit of detection for at least 36 months.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Schürmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schürmann, D., Wesselmann, H., Kurowski, M. et al. Kaletra® Single Agent HAART after Intolerance of NRTI- and NNRTI-Containing Regimens Following Kidney Transplantation. Infection 35, 194 (2007). https://doi.org/10.1007/s15010-007-6084-1

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1007/s15010-007-6084-1

Keywords

Navigation